ARIAD Pharmaceuticals is an emerging worldwide oncology company engaged in discovering, developing and commercializing medicines to change the lives of cancer patients. The company’s approach to structure-based drug design has resulted in several internally discovered, molecularly targeted product candidates for drug-resistant or hard-to-treat cancers, including certain forms of chronic myeloid leukemia and non-small cell lung cancer. For more information, visit the company’s Web site at www.ariad.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: